Product Information
ROPINIROLE HCL 4 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0804 per EA under NDC 62332003531. Its NADAC has been published 529 times since May 11, 2016.
Strength
4 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332003531
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090429On Market Since
1/29/2016
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 4 MG TABLET has been published 529 times since May 11, 2016, and over the history we have for it it has declined 25.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0804 per EA |
|---|---|
| All-time high | $0.1351 (Aug 10, 2016) |
| All-time low | $0.0681 (Nov 20, 2024) |
| 52-week high | $0.0852 |
| 52-week low | $0.0771 |
| Median price | $0.0939 |
| Average price | $0.0963 |
| Largest weekly change | +41.3% (Dec 22, 2021) |
| Weeks tracked | 529 |
| Tracking since | May 11, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ROPINIROLE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 4 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0804 per EA (NDC 62332003531), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 4 MG TABLET has declined 25.7%. It has been tracked across 529 weekly CMS publications since May 11, 2016.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 4 MG TABLET?
Since May 11, 2016, the NADAC for ROPINIROLE HCL 4 MG TABLET has ranged from a low of $0.0681 (Nov 20, 2024) to a high of $0.1351 (Aug 10, 2016), with a median of $0.0939 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 4 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ROPINIROLE HCL 4 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ROPINIROLE HCL 4 MG TABLET?
ROPINIROLE HCL 4 MG TABLET (NDC 62332003531) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification